Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This study aims to explore time-of-day of administration of immunochemotherapy on the
efficacy for treatment naive advanced non-small cell lung cancer.